FDA Accepts Supplement for Metformin Hydrochloride by Alkem
The FDA has accepted the supplemental application ANDA091184 for Metformin Hydrochloride submitted by Alkem.
Asset / Drug
Drug and asset intelligence for Alkem with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.